FCM
BBC icon

Firestone Capital Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Firestone Capital Management’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$1K – 435
2020
Q1 		$1K Hold
50
– – ﹤0.01% 420
2019
Q4 		$2K Buy
+50
New +$1.49K ﹤0.01% 418

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FEM
Fulcrum Equity Management Plano, Texas $136M AUM 42.95% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Firestone Capital Management's BBC Position: Q2 2020 in Review

Firestone Capital Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2020, closing a stake of 50 shares — an estimated $1K sold.

Firestone Capital Management first reported a position in BBC in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q4 2019. 19 funds tracked by Wall St. Rank hold BBC as of Q2 2020.

  • Firestone Capital Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2020 after selling out during the quarter.
  • Firestone Capital Management sold 50 Virtus Biotech Clinical Trials ETF shares in Q2 2020, an estimated $1K.
  • Firestone Capital Management first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2019 and held it in 2 quarters.
  • Firestone Capital Management's Virtus Biotech Clinical Trials ETF position peaked at $2K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2020.

Based on Firestone Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.